Chimeric receives $1.62M advance on FY26 R&D tax incentive
- Date and time
- Announcement type
- Capital Raising
Show detailsHide details
- Category
- Other
- Report codes
- 03022, 11001
- Sector
- Health Care
- Industry group
- Pharmaceuticals, Biotechnology & Life Sciences